Long-Term or Recurrent Antibiotic Use in Early Life and the Risk of Type 2 Diabetes: A Population-Based Prospective Cohort and a Case-Control Study

J Diabetes. 2025 Jun;17(6):e70113. doi: 10.1111/1753-0407.70113.

Abstract

Background: Antibiotics in childhood are commonly used and have been linked to gut microbiome dysbiosis and metabolic disorders. However, direct evidence regarding the association between long-term or recurrent antibiotic use (LRAU) during early life and diabetes was scarce. We performed this study to investigate this association in two population-based studies.

Methods: We undertook a prospective analysis encompassing 147 010 participants from the UK Biobank. Cox proportional hazard regression was used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) of self-reported LRAU during early life on diabetes risk. We also conducted a case-control study within the Chinese population, in which 263 diabetes cases and 526 controls were matched for age and living location. Odds ratios (ORs) and 95% CI were was calculated using logistic regression models.

Results: We identified 4314 incident cases of type 2 diabetes over 1 840 944 person-years of follow-up in the UK Biobank. LRAU during early life was associated with a 26% higher risk of diabetes after accounting for putative risk factors (HR, 1.26; 95% CI, 1.16-1.37) in the UK biobank. We observed a more evident association between LRAU and an elevated risk of diabetes in the case-control study (OR, 3.32; 95% CI, 2.06-5.38). The primary finding was robust to several subgroup analyses and sensitivity analyses.

Conclusions: LRAU during early life may increase the risk of type 2 diabetes. Caution should be exercised when prescribing long-term or recurrent antibiotics to children and adolescents.

Keywords: UK biobank; antibiotics; case–control study; cohort study; type 2 diabetes.

MeSH terms

  • Adolescent
  • Adult
  • Anti-Bacterial Agents* / adverse effects
  • Case-Control Studies
  • Child
  • Diabetes Mellitus, Type 2* / chemically induced
  • Diabetes Mellitus, Type 2* / epidemiology
  • Female
  • Follow-Up Studies
  • Gastrointestinal Microbiome / drug effects
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Risk Factors
  • United Kingdom / epidemiology

Substances

  • Anti-Bacterial Agents